Although anti-EGFL7 therapy alone could not sufficiently control tumor growth, the current state of research indicates that combining anti-EGFL7 therapy with other anti-cancer strategies such as chemotherapy might improve the efficacy of conventional anti-cancer strategies. Here, EGFL7 is linked to neoplasm.